UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000047689 |
|---|---|
| Receipt number | R000054372 |
| Scientific Title | Analysis of predicted factors in severe tuberculosis and non-tuberculosis mycobacterium patients. |
| Date of disclosure of the study information | 2022/05/09 |
| Last modified on | 2022/05/09 16:31:17 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Analysis of predicted factors in severe tuberculosis and non-tuberculosis mycobacterium patients.
Acronym
Predicted factors in severe mycobacterium patients.
Scientific Title
Analysis of predicted factors in severe tuberculosis and non-tuberculosis mycobacterium patients.
Scientific Title:Acronym
Predicted factors in severe mycobacterium patients.
Region
| Japan |
Condition
Condition
tuberculosis and non-tuberculosis mycobacterium
Classification by specialty
| Medicine in general | Infectious disease |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Analysis of predicted factors of severe mycobacterium diseases
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Analysis of predicted factors of severe mycobacterium diseases
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 1 | years-old | <= |
Age-upper limit
| 100 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Mycobacterium patients
Low oxygen
Positive from blood culture
accept the IC
Key exclusion criteria
Not accept the IC
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Masafumi |
| Middle name | |
| Last name | Seki |
Organization
Saitama Medical University, International Medical Center
Division name
Division of Infectious Diseases and Infection Control
Zip code
350-1298
Address
Yamane 1397-1, Hidaka City, Saitama, Japan
TEL
042-984-4392
sekimm@saitama-med.ac.jp
Public contact
Name of contact person
| 1st name | Masafumi |
| Middle name | |
| Last name | Seki |
Organization
Saitama Medical University, International Medical Center
Division name
Division of Infectious Diseases and Infection Control
Zip code
350-1298
Address
Yamane1397-1, Hidaka City, Saitama, Japan
TEL
042-984-4392
Homepage URL
sekimm@saitama-med.ac.jp
Sponsor or person
Institute
Saitama Medical University, International Medical Center
Institute
Department
Personal name
Funding Source
Organization
Saitama Medical University, International Medical Center
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Saitama Medical University, International Medical Center
Address
Division of Infectious Diseases and Infection Control
Tel
042-984-4392
sekimm@saitama-med.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 05 | Month | 09 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2022 | Year | 05 | Month | 09 | Day |
Date of IRB
Anticipated trial start date
| 2022 | Year | 06 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
None
Management information
Registered date
| 2022 | Year | 05 | Month | 09 | Day |
Last modified on
| 2022 | Year | 05 | Month | 09 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054372
